{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:53:55Z","timestamp":1791910435074,"version":"4.3.4"},"reference-count":31,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","whijournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Women's Health Issues"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.whi.2017.05.002","type":"journal-article","created":{"date-parts":[[2017,6,20]],"date-time":"2017-06-20T12:00:17Z","timestamp":1497960017000},"page":"646-651","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Initiation and Engagement with Methadone Treatment among Pregnant and Postpartum Women"],"prefix":"10.1016","volume":"27","author":[{"given":"Kristin M.","family":"Mattocks","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6779-3736","authenticated-orcid":false,"given":"Robin","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Weinreb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.whi.2017.05.002_bib1","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1136\/bmj.39514.554375.AE","article-title":"Pregnancy and injecting drug use","volume":"336","author":"Bell","year":"2008","journal-title":"British Medical Journal"},{"key":"10.1016\/j.whi.2017.05.002_bib2","series-title":"Medication-assisted treatment for opioid addiction in opioid treatment programs. Treatment improvement protocol (TIP) series 43","year":"2005"},{"key":"10.1016\/j.whi.2017.05.002_bib3","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1111\/j.1360-0443.2012.03844.x","article-title":"Methadone and perinatal outcomes: A prospective cohort study","volume":"107","author":"Cleary","year":"2012","journal-title":"Addiction"},{"key":"10.1016\/j.whi.2017.05.002_bib4","series-title":"Basics of qualitative research: Techniques and procedures for developing grounded theory","author":"Corbin","year":"2015"},{"key":"10.1016\/j.whi.2017.05.002_bib6","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1046\/j.1360-0443.2000.9556874.x","article-title":"Cognitive impairment among methadone maintenance patients","volume":"95","author":"Darke","year":"2000","journal-title":"Addiction"},{"key":"10.1016\/j.whi.2017.05.002_bib7","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ntt.2013.04.006","article-title":"Psychosocial characteristics and poly-drug use of pregnant women enrolled in methadone maintenance treatment","volume":"38","author":"Davie-Gray","year":"2013","journal-title":"Neurotoxicology and Teratology"},{"key":"10.1016\/j.whi.2017.05.002_bib8","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/j.1471-0528.2008.02073.x","article-title":"Maternal methadone use in pregnancy: Factors associated with the development of neonatal abstinence syndrome and implications for health care resources","volume":"116","author":"Dryden","year":"2009","journal-title":"British Journal of Obstetrics and Gynaecology"},{"key":"10.1016\/j.whi.2017.05.002_bib9","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0376-8716(01)00171-5","article-title":"Retention rate and illicit opioid use during methadone maintenance interventions: A meta-analysis","volume":"65","author":"Farr\u00e9","year":"2002","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.whi.2017.05.002_bib10","series-title":"Primary pediatric care","first-page":"1367","article-title":"Neonatal abstinence syndrome","author":"Finnegan","year":"1992"},{"key":"10.1016\/j.whi.2017.05.002_bib11","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.nwh.2016.04.024","article-title":"Development, implementation, and evaluation of a pilot parenting educational intervention in pregnancy buprenorphine clinic","volume":"20","author":"Giles","year":"2016","journal-title":"Nursing for Womens Health"},{"key":"10.1016\/j.whi.2017.05.002_bib12","series-title":"First stage trauma treatment: A guide for mental health professional working with women","author":"Haskell","year":"2003"},{"key":"10.1016\/j.whi.2017.05.002_bib13","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1016\/j.socscimed.2007.01.011","article-title":"Agency and dependency within treatment: Drug treatment clients negotiating methadone and antidepressants","volume":"64","author":"Holt","year":"2007","journal-title":"Social Science & Medicine"},{"issue":"2 suppl","key":"10.1016\/j.whi.2017.05.002_bib14","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1016\/S0376-8716(03)00062-0","article-title":"Use of buprenorphine in pregnancy: Patient management and effects on the neonate","volume":"70","author":"Johnson","year":"2003","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.whi.2017.05.002_bib15","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jsat.2007.10.007","article-title":"Treatment of opioid-dependent pregnant women: Clinical and research issues","volume":"35","author":"Jones","year":"2008","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.whi.2017.05.002_bib16","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1056\/NEJMoa1005359","article-title":"Neonatal abstinence syndrome after exposure to methadone or buprenorphine","volume":"363","author":"Jones","year":"2010","journal-title":"New England Journal of Medicine"},{"issue":"Suppl 1","key":"10.1016\/j.whi.2017.05.002_bib17","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1360-0443.2012.04035.x","article-title":"Buprenorphine treatment for opioid-dependent pregnant women: A comprehensive review","volume":"107","author":"Jones","year":"2012","journal-title":"Addiction"},{"key":"10.1016\/j.whi.2017.05.002_bib18","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1080\/10550881003684723","article-title":"Addiction in pregnancy","volume":"29","author":"Keegan","year":"2009","journal-title":"Journal of Addictive Medicine"},{"key":"10.1016\/j.whi.2017.05.002_bib19","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1097\/ADM.0000000000000308","article-title":"Treating women who are pregnant and parenting for opioid use disorder and the concurrent care of their infants and children: Literature review to support national guidance","volume":"11","author":"Klaman","year":"2017","journal-title":"Journal of Addiction Medicine"},{"issue":"2","key":"10.1016\/j.whi.2017.05.002_bib20","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1097\/GRF.0000000000000098","article-title":"Caring for opioid-dependent pregnant women: Prenatal and postpartum care considerations","volume":"58","author":"Krans","year":"2015","journal-title":"Clinical Obstetrics and Gynecology"},{"issue":"1","key":"10.1016\/j.whi.2017.05.002_bib21","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jsat.2014.07.007","article-title":"Recent trends in treatment admissions for prescription opioid abuse during pregnancy","volume":"48","author":"Martin","year":"2015","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.whi.2017.05.002_bib22","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1080\/10550490902772975","article-title":"Psychopharmacologic management of opioid-dependent women during pregnancy","volume":"18","author":"Martin","year":"2009","journal-title":"American Journal on Addictions"},{"key":"10.1016\/j.whi.2017.05.002_bib23","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ypmed.2015.07.015","article-title":"Caring for pregnant opioid abusers in Vermont: A potential model for non-urban areas","volume":"80","author":"Meyer","year":"2015","journal-title":"Preventive Medicine"},{"key":"10.1016\/j.whi.2017.05.002_bib24","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jsat.2010.03.008","article-title":"Trends in methadone maintenance treatment participation, retention, and compliance to dosing guidelines in British Columbia, Canada: 1996-2006","volume":"39","author":"Nosyk","year":"2010","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.whi.2017.05.002_bib25","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jsat.2014.04.004","article-title":"Postpartum changes in methadone maintenance dose","volume":"47","author":"Pace","year":"2014","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.whi.2017.05.002_bib26","first-page":"193","article-title":"Neonatal abstinence syndrome and associated health care expenditures: United States, 2000-2009","volume":"307","author":"Patrick","year":"2012","journal-title":"Journal of the American Medical Association"},{"issue":"3","key":"10.1016\/j.whi.2017.05.002_bib27","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.whi.2010.02.003","article-title":"Women\u2019s perspectives on screening for alcohol and drug use in prenatal care","volume":"20","author":"Roberts","year":"2010","journal-title":"Women\u2019s Health Issues"},{"issue":"3","key":"10.1016\/j.whi.2017.05.002_bib28","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s10995-010-0594-7","article-title":"Complex calculations: How drug use during pregnancy becomes a barrier to prenatal care","volume":"15","author":"Roberts","year":"2011","journal-title":"Maternal and Child Health Journal"},{"issue":"3","key":"10.1016\/j.whi.2017.05.002_bib29","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/1468-0009.12137","article-title":"Where is buprenorphine dispensed to treat opioid use disorders? The role of private offices, opioid treatment programs, and substance abuse treatment facilities in urban and rural counties","volume":"93","author":"Stein","year":"2015","journal-title":"Milbank Quarterly"},{"key":"10.1016\/j.whi.2017.05.002_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40352-015-0015-5","article-title":"Pregnant women and substance use: Fear, stigma, and barriers to care","volume":"3","author":"Stone","year":"2015","journal-title":"Health and Justice"},{"key":"10.1016\/j.whi.2017.05.002_bib31","series-title":"Results from the 2012 National Survey on Drug Use and Health: National Findings. NHSDA Series H-46, HHS Publication No. (SMA) 13\u20134795","year":"2013"},{"issue":"2","key":"10.1016\/j.whi.2017.05.002_bib32","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/AOG.0000000000000640","article-title":"Buprenorphine and naloxone compared with methadone treatment in pregnancy","volume":"125","author":"Wiegand","year":"2015","journal-title":"Obstetrics and Gynecology"}],"container-title":["Women's Health Issues"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1049386716303073?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1049386716303073?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,31]],"date-time":"2018-08-31T15:25:41Z","timestamp":1535729141000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1049386716303073"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["S1049386716303073"],"URL":"https:\/\/doi.org\/10.1016\/j.whi.2017.05.002","relation":{},"ISSN":["1049-3867"],"issn-type":[{"value":"1049-3867","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Initiation and Engagement with Methadone Treatment among Pregnant and Postpartum Women","name":"articletitle","label":"Article Title"},{"value":"Women's Health Issues","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.whi.2017.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier Inc. on behalf of Jacobs Institute of Women's Health.","name":"copyright","label":"Copyright"}]}}